Alexium International Group Ltd (ASX: AJX) Share Price and News

Mr Moore is the Senior Partner of the investment firm, Colinton Capital Partners. Prior to establishing Colinton Capital Partners in 2017, Mr Moore was a Global Partner of The Carlyle Group having established their operation in Australia in 2005. In his time at The Carlyle Group, he oversaw the Firm's investments in and served on the Boards of Directors of Coates Hire, Healthscope and Qube. Mr Moore is currently Chair of the Audit Committee and a member of the Risk Committees.

Dr Brookins has more than 15 years of experience in organic synthesis and materials chemistry. Upon completion of his PhD, he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed synthetic routes for reactive and functional surfaces. In 2010, Dr Brookins joined Alexium where he and his team pioneered new classes of flame-retardants for textile markets. Additionally, his research focuses on phase change materials, particularly application methods and analytical tools.

Dr Stenson is the chair of the Risk Committee. Dr Stenson has a career with the research, development, manufacture, and commercialisation of new materials in the fields of coatings, adhesives, nonwovens, and pharmaceuticals.

Mr Dennis is an operational management professional with over 25 years of experience with expertise in Consumer and Pharmaceutical Goods. As a former CEO and commercial director, Mr Dennis has skills in new product development, sales and marketing, international brand management and operational execution. Mr Dennis was the CEO and co-owner of Vital Merchandising Services Pty Ltd for 11 years which was acquired by Imperial Logistics Limited in 2007 and he went on to hold both operational and business development C-suite roles with Imperial Logistics as part of the DP World Group. Throughout his career, his clients have included Blue Chip FMCG organisations with global brands. Over the past seven years Mr Dennis has focused on creating new markets for international Australian consumer brands across Asia, the Middle East, and Africa.

Mr Blackburn has over 25-years of experience in general management, with record of driving commercial growth. He has enjoyed accomplishment as both an entrepreneur and as an executive in organizations. He founded Emes, a technology-based specialty chemical business. Emes had a business model focused on chemical production paired with recycling in the pharmaceutical and consumer healthcare markets. Mr. Blackburn sold the business to Nova Molecular. He joined their executive team to lead further commercial growth of the merged organisations.

-

-

-

-